Journal: Scientific reports
Article Title: RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel.
doi: 10.1038/s41598-025-85774-w
Figure Lengend Snippet: Fig. 4. Combination treatment with PTX and RSL3 activates NF-κB and promotes TNBC cell death. (A) The viability of MDA-MB-231 and MDA-MB-468 cells was assayed using the CCK-8 assay after combination treatment with PTX or RSL3 and an NF-κB inhibitor for 24 h. (B) After the treatments, the expression levels of cytokines were detected by RT-qPCR. (C) After the treatments, the expression levels of cytokines were detected by Western blotting and ELISA. (D) The protein expression levels of P65, P-P65 and GPX4 were measured by Western blotting, and a grayscale map of protein expression is displayed. **P < 0.01; *P < 0.05; ****p < 0.0001; ***p < 0.001. NS: Not significant.
Article Snippet: NF-κB p65 (D14E12) rabbit monoclonal antibody (8242), phosphoNF-κB p65 (Ser536) rabbit monoclonal antibody (3033), and anti-rabbit IgG (H + L) (DyLightTM 800 4X PEG Conjugate) rabbit secondary antibody (5151) were purchased from Cell Signaling Technology (CST).
Techniques: CCK-8 Assay, Expressing, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay